| N = 64 (%) |
---|---|
Age | Â |
 ≤ 60 | 34 (53.1) |
 > 60 | 30 (46.9) |
Gender | Â |
 Male | 55 (85.9) |
 Female | 9 (14.1) |
Smoking | Â |
 < 10 pk yrs | 34 (53.1) |
 ≥ 10 pk yrs | 30 (46.9) |
T stage | Â |
 1 | 17 (26.6) |
 2 | 22 (34.3) |
 3 | 12 (18.8) |
 4 | 13 (20.3) |
N stage | Â |
 1 | 33 (51.6) |
 2 | 30 (46.9) |
 3 | 1 (1.6) |
Overall stage | Â |
 I | 25 (39.1) |
 II | 17 (26.6) |
 III | 16 (25.0) |
 IV | 5 (7.8) |
P16 status | Â |
 Positive | 58 (90.1) |
 Negative | 6 (9.4) |
Concurrent chemotherapy | Â |
 Yes | 57 (89.1) |
 No | 7 (10.1) |
Subsite | Â |
 BoT | 30 (46.9) |
 Tonsil | 29 (45.3) |
 Soft palate | 3 (4.7) |
 Pharyngeal wall | 2 (3.2) |